- Infinity, MedImmune, AZ restructure Hedgehog deal
- Roche gets a group of HCV protease inhibitors from InterMune
- Lilly pays Icos $75mm up front to establish JV
- Lilly agrees to buy Icos for $2.1bn
- Miles & Onyx will jointly R&D small-molecule drugs
- GSK adds antibody expertise through £230mm Domantis buy
- Merck buys Sirna for $1.1bn
- AZ and BMS enter Type II diabetes deal; BMS later sells diabetes business to AZ
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.